| 1.47 Data as of May 22 |  -0.13 / -8.13%Today’s Change | 0.98 Today|||52-Week Range 2.25 | +8.09% Year-to-Date |
| SECTOR Consumer Non-Durables | INDUSTRY Household/Personal Care | MARKET CAP $23.3M |
Company Description
ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products in the United States. The company also engages in research and development of potential over-the-counter drug, natural base health products along with supplements, personal care and cosmeceutical products. Its products include Cold-EEZE Cold Remedy, Kids-EEZE Symptom Reliever and Organix cough and cold drops. Its customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.
Employees
Shareholders
| Other institutional | 4.57% |
| Individual stakeholders | 37.32% |
| Mutual fund holders | 1.42% |
Top Executives
| Ted William Karkus, MBA | Chairman, CEO & Investor Relations |
| Robert V. Cuddihy, Jr., CPA | Executive VP, Chief Operating & Financial Officer |
.
